Smart and Personalized Migraine Treatment
Neurawave is a Swedish company focused on developing innovative solutions for migraine relief. Neurawave's vision is to eliminate all migraine pain. Our mission is to give everyone with migraine control over their migraine and their lives.
Migraine – A Public Health Issue
According to the World Health Organization (WHO), headache disorders affected approximately 40% of the global population in 2021. Migraine is a common type of headache disorder that can affect both adults and children. An alternative to medication is needed, as its effect can diminish over time or not work at all for everyone.
1 in 7
People globally
Migraine affects ~15% of the world's population — more commonly women than men.
Genetic
Strong hereditary link
Family history significantly raises the risk, especially for migraine with aura.
25%
Experience aura
Visual disturbances, flashes of light, or temporary vision loss before the headache.
Relief aHead – Your Personal Solution for Migraine
A complete ecosystem of hardware and software. Paying customers in Chile, 10,000+ app downloads, and available on Google Play.
Available in Chile — more markets coming
Overview & Predictions
See your migraine risk in real time and get personalized insights
Treatment
Start and follow your treatment with a single tap
Product availability and intended use may vary between markets. See the respective webshop and app store for details. Always consult a healthcare professional before making medical decisions.
Traction
Launched in Chile in April 2026 with paying customers, 10,000+ app downloads, and growing.
Our Vision – Accessible Migraine Relief for Everyone
We want to make migraine treatment simple and accessible for everyone. Our vision is to combine smart technology with personalized care so that more people can find relief and gain control over their migraine.
Personalized treatment tailored to your unique needs and preferences.
Scientifically proven nerve stimulation for both preventive treatment and acute relief.
AI-driven prediction that anticipates migraine attacks before the pain begins.
Roadmap
Where we've been, where we are, and where the investment goes.
- ✓Done
Product built & app launched
Hardware and software developed from the ground up. App is live on Google Play and the App Store in Chile.
- ✓April 2026 — Done
First sale — Chile launch
Relief aHead commercially available in Chile. Paying customers, 10,000+ app downloads, one active market.
- →Now — In progress
Growing user base & fundraising
Scaling Chile operations, onboarding new users, and raising the round that funds EU regulatory clearance.
- 1Next
Clinical study — Karolinska University Hospital
Partnered clinical study to generate the evidence base required for EU regulatory approval.
- 2Next
CE marking under MDR
EU medical device certification — the regulatory milestone that unlocks the full European market.
- 3Next
EU launch
Commercial rollout across European markets, starting with the Nordics. 40M+ migraine sufferers in the EU.
Meet our team
We are a dedicated team with expertise in medical technology, software development, innovation and AI, working from Kalmar to develop tomorrow's solutions for migraine. See open positions
Latest News
Half a Year in Chile — A 2026 Recap
Since launching Relivia in Chile in April 2026, we ran our 'Rompemos el silencio' campaign during Migraine Awareness Month, built collaborations with Chile's largest migraine community, and have received amazing feedback from our customers.
August 13, 2026
Building Automated Testing for e-TNS Treatment
Great engineering often goes unseen — but it shows in every unit that reaches our users. Our team is building automated testing for the e-TNS treatment, making our test and production flow smoother as we scale.
August 10, 2026
Kalmar Municipality Leadership Visited Neurawave
We had the honor of welcoming the leadership of Kalmar Municipality and presenting Neurawave and the product Relief aHead. An inspiring meeting about how technology can change the lives of those living with migraine.
May 6, 2026
Contact us
We look forward to hearing from you
Whether you have questions, ideas, are interested in working with us, or want to book a meeting — don't hesitate to reach out.
Address: Bredbandet 1, Varvsholmen, Kalmar
Email: contact@neurawave.se